Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details Narrative)

v3.19.1
Stockholders' Equity (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2018
Mar. 31, 2019
Jun. 30, 2018
Weighted average grant fair value (in dollars per share)   $ 2.82  
Accrued stock compensation expenses   $ 192,158 $ 395,539
Number of shares issued (in shares) 7,250,000    
Number of shares issued (in dollars per share) $ 4.25    
Gross proceeds from issuance of shares $ 30,800,000    
Commissions on issuance of shares $ 2,100,000    
Dividend yield   0.00%  
Investor [Member] | Private Placement [Member]      
Number of shares issued (in shares)   113,592  
Closing date   2017-05  
Restricted Stock Units [Member]      
Number of shares granted   676,880  
Weighted average grant fair value (in dollars per share)   $ 6.10  
Vesting period   4 years  
Performance-Based Restricted Stock Units [Member]      
Number of shares granted   119,500  
Weighted average grant fair value (in dollars per share)   $ 8.30  
Employees And Directors [Member]      
Number of shares granted   953,455  
Weighted average grant fair value (in dollars per share)   $ 2.82